Effect of Interleukin 6 on Scleral Fibroblast Proliferation, Differentiation, and Apoptosis Involved in Myopic Scleral Remodeling
Authors:
Open Access
- 11 April 2022
- journal article
- research article
- Published by S. Karger AG in Ophthalmic Research
- Vol. 65 (5) , 529-539
Abstract
Introduction: Scleral hypoxia (HO) is present in myopic eyes, and interleukin (IL)-6 is increased in the aqueous humor of patients with high myopia. The aim of this study was to investigate the effects of IL-6 on scleral fibroblast proliferation, differentiation, and apoptosis under conditions of HO and the possible role of IL-6 in myopic scleral remodeling. Methods: Primary human scleral fibroblasts (HSFs) were cultured using a tissue mass adherent method. First, cells were cultured under conditions of HO (2% O2) or normoxia (NO, 20% O2) for different times. A quantitative real-time polymerase chain reaction (qRT-PCR) and immunofluorescence were used to detect the expression of IL-6 in HSFs. Next, cells were divided into five groups: NO, HO, HO plus IL-6, HO plus IL-6 receptor inhibitor (IL6RI), and HO plus IL-6 and IL6RI. The groups were treated separately for 72 h. Cell counting kit-8 assay and flow cytometry were used to detect cell proliferation and apoptosis, respectively. Western blotting and qRT-PCR were used to detect the expression of various genes in the transforming growth factor-β1/Smad2/matrix metalloproteinase-2 pathway; these methods and immunofluorescence were also used to detect transdifferentiation of HSFs. Results: HO resulted in upregulation of IL-6 expression in HSFs. Compared with NO, HO resulted in diminished cell proliferation and increased apoptosis and differentiation in HSFs; the above trend was further enhanced by the addition of IL6RI. Compared with the HO group, the addition of IL-6 led to a decrease in cell proliferation and an increase in apoptosis and differentiation of HSFs; the above trends showed opposite changes after the addition of both IL-6 and IL6RI. Additionally, IL-6 and IL6RI exerted opposite regulatory effects on the transforming growth factor-β1/Smad2/matrix metalloproteinase-2 pathway under conditions of HO. Conclusion: HO caused HSFs to overexpress IL-6. IL-6 has a role in scleral remodeling in myopic eyes through affecting the proliferation, differentiation, and apoptosis of HSFs.Keywords
This publication has 16 references indexed in Scilit:
- Acquired myopia in Vogt–Koyanagi–Harada diseaseInternational Ophthalmology, 2018
- Tocilizumab (Actemra)Human Vaccines & Immunotherapeutics, 2017
- Interleukin-6 Signaling Pathway and Its Role in Kidney Disease: An UpdateFrontiers in Immunology, 2017
- Myofibroblast repair mechanisms post-inflammatory response: a fibrotic perspectiveInflammation Research, 2016
- The role of interleukin-6 signaling in nervous tissueBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2016
- Interleukin-6: Biology, signaling and strategies of blockadeCytokine & Growth Factor Reviews, 2015
- IL-6 as a keystone cytokine in health and diseaseNature Immunology, 2015
- Regulation of scleral metabolism in myopia and the role of transforming growth factor-betaExperimental Eye Research, 2013
- IL-6 Trans-Signaling via the Soluble IL-6 Receptor: Importance for the Pro-Inflammatory Activities of IL-6International Journal of Biological Sciences, 2012
- IL-6 signal transduction and its physiological roles: the signal orchestration model2003